SCHEMBL4902506

SCHEMBL4902506

CCN(c1nc(-c2ccc(Cl)cc2)sc1C)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
KDM4E B2RXH2 2/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 2/20 0.39
TRPM8 Q7Z2W7 2/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904159 0.92 MEN1 (0.52) LMNAKMT2AMEN1KDM4ERAB9A
SCHEMBL4901463 0.92 ALDH1A1 (0.44) LMNAKMT2AMEN1KDM4ERAB9A
SCHEMBL4904475 0.91 LMNA (0.42) LMNAKMT2AMEN1KDM4ERAB9A
SCHEMBL4904348 0.91 LMNA (0.47) LMNAKMT2AMEN1RAB9ANPC1
SCHEMBL4907121 0.91 LMNA (0.47) LMNAKMT2AMEN1ALDH1A1HPGD
SCHEMBL4904293 0.90 LMNA (0.45) LMNAKMT2AALDH1A1HPGDALOX15
SCHEMBL4906767 0.90 ALDH1A1 (0.44) LMNAKMT2AMEN1KDM4ERAB9A
SCHEMBL4904359 0.90 KDM4E (0.40) LMNAKMT2AMEN1KDM4ERAB9A
SCHEMBL4904191 0.89 LMNA (0.42) LMNAKMT2AMEN1KDM4ERAB9A
SCHEMBL4907195 0.89 LMNA (0.39) LMNAKMT2AMEN1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885KMT2A 3530/4885MEN1 4855/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885KMT2A 3530/4885MEN1 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.